Sponsor
Guangzhou 8th People's Hospital
Clinical research sponsor
Clinical trials
14 shownRisk Identification Factors for Pulmonary Function Impairment in AIDS Patients Recovered From Severe PneumoniaNCT06137196 · lead sponsor · 2023-11-01
RECRUITINGMetagenomic Next-Generation Sequencing Guides Anti-Infection StrategiesNCT06145841 · lead sponsor · 2023-10-23
RECRUITINGClinical Application of Cytokine Adsorption Technique in AIDS Patients With Severe Pneumonia and/or Septic ShockNCT06145828 · lead sponsor · 2023-10-23
RECRUITINGFunctional Cure of Hepatitis B in HIV/HBV Co-infected PatientsNCT05988879 · lead sponsor · 2023-08-02
RECRUITINGDolutegravir Plus Lamivudine Simplified TherapyNCT03884673 · lead sponsor · 2019-01-01
RECRUITINGSimplified Treatment of Anti-retrovirus in China (C-STAR)NCT03603977 · lead sponsor · 2017-11-01
RECRUITINGThe Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune FunctionNCT03240328 · lead sponsor · 2017-10-04
RECRUITINGObservational Study on Patients With HIV/AIDS(OSPWH)NCT04667026 · lead sponsor · 2009-01-01
RECRUITINGEfficacy and Safety of Ainuovirine Treating With AIDS PatientsNCT05420246 · lead sponsor · 2022-05-01
UNKNOWNThe Effect of Arsenic Trioxide on Eliminating HIV-1 Reservoir Combined With cARTNCT03980665 · lead sponsor · 2019-04-01
UNKNOWNEffect of Chidamide Combined With CAT-T or TCR-T Cell Therapy on HIV-1 Latent ReservoirNCT03980691 · lead sponsor · 2017-12-01
COMPLETEDReconstitution of HIV-specific Immunity Against HIVNCT02563509 · lead sponsor · 2016-01-01
COMPLETEDA Promotion and Implementation Project of HIV Pre-Exposure Prophylaxis Among High Risk PopulationNCT04754139 · collaborator · 2021-09-24
COMPLETEDA Drug Safety and Dose-exploratory Clinical Study of Azvudine Tablets in Patients Who Have Not Received Anti-HIV TreatmentNCT04109183 · collaborator · 2017-10-10
COMPLETEDSponsor roles
lead sponsor12
collaborator2
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.